Replies to post #4406 on OTC IPOs, Mergers & Other Material Events

[Hanibal]

Lilly disappointed with their Alzheimers trial today and that makes LGVN and other small cap Alzheimers plays look more attractive in my opinion.

I am expecting some data to come in for LGVN this month. I can see it pulling a SAVA type move if the data is good. Albeit it's only phase 1 so who knows